Feihong Deng

1.8k total citations
31 papers, 1.4k citations indexed

About

Feihong Deng is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Feihong Deng has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Genetics. Recurrent topics in Feihong Deng's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Feihong Deng is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Feihong Deng collaborates with scholars based in China and United States. Feihong Deng's co-authors include Qiming J. Wang, Xiaonan Liu, Fanning Zeng, Deliang Liu, Fachao Zhi, Biao Nie, Jinmin Chen, Liang Peng, Jinfeng Lin and Allen T. Yu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and World Journal of Gastroenterology.

In The Last Decade

Feihong Deng

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feihong Deng China 14 683 420 351 326 206 31 1.4k
Ashis K. Mondal United States 22 863 1.3× 326 0.8× 159 0.5× 289 0.9× 147 0.7× 75 1.7k
So Yeon Kim South Korea 19 637 0.9× 202 0.5× 169 0.5× 562 1.7× 304 1.5× 34 1.6k
Sadeesh K. Ramakrishnan United States 20 710 1.0× 435 1.0× 115 0.3× 301 0.9× 265 1.3× 38 1.6k
Wen Zhou China 25 658 1.0× 146 0.3× 615 1.8× 449 1.4× 244 1.2× 110 1.9k
Lina He United States 18 872 1.3× 315 0.8× 94 0.3× 234 0.7× 107 0.5× 32 1.4k
Eleni Stylianou United Kingdom 20 597 0.9× 223 0.5× 285 0.8× 154 0.5× 454 2.2× 32 1.4k
Yanan Zhu China 24 1.1k 1.6× 782 1.9× 87 0.2× 219 0.7× 172 0.8× 72 1.8k
Sally Thomas United Kingdom 14 494 0.7× 157 0.4× 419 1.2× 403 1.2× 225 1.1× 26 1.6k
Sen Lu China 26 870 1.3× 654 1.6× 112 0.3× 130 0.4× 133 0.6× 62 1.6k
Yan He China 20 772 1.1× 510 1.2× 108 0.3× 142 0.4× 314 1.5× 118 1.5k

Countries citing papers authored by Feihong Deng

Since Specialization
Citations

This map shows the geographic impact of Feihong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feihong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feihong Deng more than expected).

Fields of papers citing papers by Feihong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feihong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feihong Deng. The network helps show where Feihong Deng may publish in the future.

Co-authorship network of co-authors of Feihong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Feihong Deng. A scholar is included among the top collaborators of Feihong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feihong Deng. Feihong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Hanyu, Feihong Deng, Min Luo, & Xuehong Wang. (2024). Case report: Fecal microbiota transplant for Clostridium difficile infection in a pregnant patient with acute severe ulcerative colitis. Frontiers in Immunology. 15. 1417003–1417003.
3.
S, Fu, Mengmeng Xu, Siyi Wang, et al.. (2024). HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway. Heliyon. 10(13). e33740–e33740. 3 indexed citations
4.
Guo, Ting, et al.. (2023). Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. Frontiers in Physiology. 14. 1098129–1098129. 13 indexed citations
5.
Liu, Deliang, et al.. (2023). Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis. Frontiers in Cellular and Infection Microbiology. 13. 1218552–1218552. 17 indexed citations
6.
Deng, Feihong, Hanyu Wang, & Xuehong Wang. (2023). Chronic Diarrhea with Villous Blunting of the Small Intestine Under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia: A Case Series. Journal of Asthma and Allergy. Volume 16. 997–1006. 4 indexed citations
7.
Zou, Fei, et al.. (2023). The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases. Frontiers in Physiology. 14. 1235656–1235656. 12 indexed citations
8.
Deng, Feihong, et al.. (2022). YAP Activates STAT3 Signalling to Promote Colonic Epithelial Cell Proliferation in DSS-Induced Colitis and Colitis Associated Cancer. Journal of Inflammation Research. Volume 15. 5471–5482. 9 indexed citations
9.
Deng, Feihong, et al.. (2022). The Hippo–YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury. Frontiers in Cell and Developmental Biology. 10. 894737–894737. 29 indexed citations
10.
Li, Bin, Kun Xie, Junwei Liu, et al.. (2022). KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells. BMC Medical Genomics. 15(1). 194–194. 3 indexed citations
11.
Liu, Deliang, et al.. (2022). The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. Journal of Inflammation Research. Volume 15. 3167–3185. 46 indexed citations
12.
Liu, Deliang, et al.. (2021). Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5. Digestive Diseases and Sciences. 66(11). 3803–3812. 13 indexed citations
13.
Deng, Feihong, et al.. (2021). Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease. International Journal of General Medicine. Volume 14. 3387–3396. 4 indexed citations
14.
Liu, Deliang, et al.. (2021). M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation. Journal of Cellular and Molecular Medicine. 25(6). 3041–3050. 38 indexed citations
15.
Tan, Yuyong, Shilan Zhang, Feihong Deng, et al.. (2019). Submucosal Tunneling Endoscopic Resection for Gastric Submucosal Tumors: a Comparison Between Cardia and Non-cardia Location. Journal of Gastrointestinal Surgery. 23(11). 2129–2135. 8 indexed citations
16.
Deng, Feihong, Liang Peng, Zhijun Li, et al.. (2018). YAP triggers the Wnt/β-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death and Disease. 9(2). 153–153. 164 indexed citations
17.
Chen, Jinmin, et al.. (2017). Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World Journal of Gastroenterology. 23(46). 8235–8247. 39 indexed citations
18.
Xu, Qiaobing, Feihong Deng, Bohong Cen, et al.. (2016). Long non-coding RNA C2dat1 regulates CaMKIIδ expression to promote neuronal survival through the NF-κB signaling pathway following cerebral ischemia. Cell Death and Disease. 7(3). e2173–e2173. 99 indexed citations
19.
Zeng, Fanning, et al.. (2016). Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death and Disease. 7(5). e2226–e2226. 398 indexed citations
20.
Lin, Jinfeng, Jinmin Chen, Allen T. Yu, et al.. (2014). Meta-analysis. Inflammatory Bowel Diseases. 20(8). 1407–1415. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashis K. Mondal Breakdown of academic impact, for papers by So Yeon Kim Breakdown of academic impact, for papers by Sadeesh K. Ramakrishnan Breakdown of academic impact, for papers by Wen Zhou Breakdown of academic impact, for papers by Lina He Breakdown of academic impact, for papers by Eleni Stylianou Breakdown of academic impact, for papers by Yanan Zhu Breakdown of academic impact, for papers by Sally Thomas Breakdown of academic impact, for papers by Sen Lu Breakdown of academic impact, for papers by Yan He
Rankless by CCL
2026